ALT vs FAST · rev $20.0K vs P/E 43, rev $7.55B
Altimmune Inc (ALT) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
ALT currently screens at market cap $527.0M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the ALT and FAST stock pages for the full models.
Not investment advice.